INHIBITION BY ERYTHROMYCIN OF THE CONVERSION OF CARBAMAZEPINE TO ITS ACTIVE 10,11-EPOXIDE METABOLITE

被引:23
作者
BARZAGHI, N [1 ]
GATTI, G [1 ]
CREMA, F [1 ]
MONTELEONE, M [1 ]
AMIONE, C [1 ]
LEONE, L [1 ]
PERUCCA, E [1 ]
机构
[1] R MARGHERITA HOSP,TURIN,ITALY
关键词
D O I
10.1111/j.1365-2125.1987.tb03257.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:836 / 838
页数:3
相关论文
共 17 条
[11]   DISPOSITION OF SODIUM VALPROATE IN EPILEPTIC PATIENTS [J].
PERUCCA, E ;
GATTI, G ;
FRIGO, GM ;
CREMA, A ;
CALZETTI, S ;
VISINTINI, D .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 5 (06) :495-499
[12]   CARBAMAZEPINE-VILOXAZINE INTERACTION IN PATIENTS WITH EPILEPSY [J].
PISANI, F ;
FAZIO, A ;
OTERI, G ;
PERUCCA, E ;
RUSSO, M ;
TRIO, R ;
PISANI, B ;
DIPERRI, R .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1986, 49 (10) :1142-1145
[13]   SODIUM VALPROATE AND VALPROMIDE - DIFFERENTIAL INTERACTIONS WITH CARBAMAZEPINE IN EPILEPTIC PATIENTS [J].
PISANI, F ;
FAZIO, A ;
OTERI, G ;
RUELLO, C ;
GITTO, C ;
RUSSO, F ;
PERUCCA, E .
EPILEPSIA, 1986, 27 (05) :548-552
[14]  
SAWCHUK RJ, 1982, CLIN CHEM, V28, P2127
[15]  
VAIDA FJE, 1984, MED J AUSTRALIA, V140, P81
[16]  
Wong Y, 1983, CLIN PHARMACOL THER, V33, P461
[17]   CARBAMAZEPINE-ERYTHROMYCIN INTERACTION - CASE-STUDIES AND CLINICAL-SIGNIFICANCE [J].
WROBLEWSKI, BA ;
SINGER, WD ;
WHYTE, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 255 (09) :1165-1167